At the end of Q2 2024, 34 institutions reported holding Phoenix Biotech Acq -CW26 (CEROW) in their 13F filings, down 3 from Q1 2024. 1 opened new positions and 4 sold out. The largest holders were Cowen and Company, LLC ($14K), Cantor Fitzgerald, L. P. ($9K) and Periscope Capital Inc. ($9K).
Company
Phoenix Biotech Acq -CW26
Filed as
CERO THERAPEUTICS HLDGS INC (Q2 2024)
CUSIP
71902K113
Latest filing quarter
Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
Institutions
Total Value
New Positions
1
$7
Exits
4
$8K
All 13F filers, Q1 2024 → Q2 2024: 257,722 shares bought and 312,240 shares sold, net −54,518 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.